$ZDGE
Zedge, Inc. Stock $zdge

$zdge Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 10-Q Financial Statement

#000121390023095720 Filed on December 14, 2023

Income Statement

Concept	2023 Q4	2023 Q3	2023 Q1
Revenue	$7.081M	$6.632M	$6.983M
YoY Change	2.62%	-10.04%	0.98%
Cost Of Revenue	$486.0K	$480.0K	$632.0K
YoY Change	-23.1%	-18.37%	84.8%
Gross Profit	$6.595M	$6.152M	$6.351M
YoY Change	5.22%	-9.32%	-3.38%
Gross Profit Margin	93.14%	92.76%	90.95%
Selling, General & Admin	$5.499M	$5.144M	$5.871M
YoY Change	-5.61%	-0.29%	89.02%
% of Gross Profit	83.38%	83.62%	92.44%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$14.00K	$764.0K	$815.0K
YoY Change	-98.23%	-2.68%	126.39%
% of Gross Profit	0.21%	12.42%	12.83%
Operating Expenses	$5.499M	$5.908M	$5.871M
YoY Change	-5.61%	-0.61%	69.39%
Operating Profit	$321.0K	$244.0K	$1.458M
YoY Change	-259.7%	-70.95%	-53.07%
Interest Expense	-$138.0K	$151.0K	$2.030M
YoY Change	-226.61%	-96.14%	-2959.15%
% of Operating Profit	-42.99%	61.89%	139.23%
Other Income/Expense, Net			$39.00K
YoY Change
Pretax Income	$183.0K	$395.0K	$1.695M
YoY Change	-175.62%	-91.68%	-44.17%
Income Tax	$198.0K	$240.0K	$89.00K
% Of Pretax Income	108.2%	60.76%	5.25%
Net Earnings	-$15.00K	$155.0K	$1.606M
YoY Change	-91.12%	-96.58%	-30.92%
Net Earnings / Revenue	-0.21%	2.34%	23.0%
Basic Earnings Per Share			$0.11
Diluted Earnings Per Share		$0.01	$0.11
COMMON SHARES
Basic Shares Outstanding	13.98M shares		14.09M shares
Diluted Shares Outstanding	13.98M shares		14.26M shares

Balance Sheet

Concept	2023 Q4	2023 Q3	2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$18.75M	$18.13M	$17.46M
YoY Change	1.77%	6.09%	-41.83%
Cash & Equivalents	$18.75M	$18.13M	$17.46M
Short-Term Investments
Other Short-Term Assets	$635.0K	$569.0K	$1.334M
YoY Change	5.66%	43.69%	239.44%
Inventory
Prepaid Expenses	$635.0K	$569.0K	$1.334M
Receivables	$3.183M	$2.883M	$2.788M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$22.56M	$21.58M	$21.58M
YoY Change	4.94%	8.47%	-35.87%
LONG-TERM ASSETS
Property, Plant & Equipment	$2.423M	$2.186M	$1.933M
YoY Change	35.44%	31.69%	-1.63%
Goodwill	$1.784M	$1.961M	$10.72M
YoY Change	-83.24%	-81.82%
Intangibles	$18.13M	$18.71M	$19.87M
YoY Change	-11.33%	-11.02%
Long-Term Investments
YoY Change
Other Assets	$439.0K	$556.0K	$326.0K
YoY Change	24.36%	39.0%	-49.85%
Total Long-Term Assets	$24.62M	$25.25M	$33.67M
YoY Change	-27.8%	-27.29%	197.14%
TOTAL ASSETS
Total Short-Term Assets	$22.56M	$21.58M	$21.58M
Total Long-Term Assets	$24.62M	$25.25M	$33.67M
Total Assets	$47.18M	$46.83M	$55.25M
YoY Change	-15.14%	-14.27%	22.83%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$815.0K	$669.0K	$1.381M
YoY Change	-40.81%	-43.31%	231.18%
Accrued Expenses	$2.906M	$2.676M	$3.174M
YoY Change	-11.94%	-7.66%	34.21%
Deferred Revenue		$2.414M
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$2.000M
YoY Change
Total Short-Term Liabilities	$5.971M	$5.759M	$7.360M
YoY Change	-23.23%	-33.48%	7.49%
LONG-TERM LIABILITIES
Long-Term Debt	$1.986M	$1.985M	$1.983M
YoY Change	0.2%
Other Long-Term Liabilities	$171.0K	$223.0K
YoY Change	755.0%	320.75%
Total Long-Term Liabilities	$2.157M	$2.208M	$1.983M
YoY Change	7.74%	4066.04%	1965.63%
TOTAL LIABILITIES
Total Short-Term Liabilities	$5.971M	$5.759M	$7.360M
Total Long-Term Liabilities	$2.157M	$2.208M	$1.983M
Total Liabilities	$8.202M	$7.967M	$9.343M
YoY Change	-29.02%	-23.67%	34.57%
SHAREHOLDERS EQUITY
Retained Earnings	-$3.957M	-$3.942M	$3.597M
YoY Change	-298.74%	-282.5%
Common Stock			$5.000K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)			$1.323M
YoY Change
Treasury Stock Shares			522.0K shares
Shareholders Equity	$38.98M	$38.86M	$45.91M
YoY Change
Total Liabilities & Shareholders Equity	$47.18M	$46.83M	$55.25M
YoY Change	-15.14%	-14.27%	22.83%

Cashflow Statement

Concept	2023 Q4	2023 Q3	2023 Q1
OPERATING ACTIVITIES
Net Income	-$15.00K	$155.0K	$1.606M
YoY Change	-91.12%	-96.58%	-30.92%
Depreciation, Depletion And Amortization	$14.00K	$764.0K	$815.0K
YoY Change	-98.23%	-2.68%	126.39%
Cash From Operating Activities	$1.260M	$419.0K	$39.00K
YoY Change	16.45%	135.39%	-98.69%
INVESTING ACTIVITIES
Capital Expenditures	$22.00K	$293.0K	$372.0K
YoY Change	-101.68%	-304.9%	-375.56%
Acquisitions
YoY Change
Other Investing Activities		$0.00
YoY Change
Cash From Investing Activities	-$445.0K	-$293.0K	-$372.0K
YoY Change	-66.06%	104.9%	175.56%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$13.00K
YoY Change	-95.81%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$10.00K	-141.0K	-679.0K
YoY Change	-100.6%	-7150.0%	-9800.0%
NET CHANGE
Cash From Operating Activities	$1.260M	419.0K	39.00K
Cash From Investing Activities	-$445.0K	-293.0K	-372.0K
Cash From Financing Activities	-$10.00K	-141.0K	-679.0K
Net Change In Cash	$620.0K	-15.00K	-1.012M
YoY Change	-53.52%	-140.54%	-135.42%
FREE CASH FLOW
Cash From Operating Activities	$1.260M	$419.0K	$39.00K
Capital Expenditures	$22.00K	$293.0K	$372.0K
Free Cash Flow	$1.238M	$126.0K	-$333.0K
YoY Change	-48.27%	-60.75%	-110.67%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q4	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q4	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023Q4	dei	Entity Small Business EntitySmallBusiness	true
CY2023Q4	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q4	dei	Entity Shell Company EntityShellCompany	false
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	18745000	usd
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	18125000	usd
CY2023Q4	dei	Document Type DocumentType	10-Q
CY2023Q4	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q4	dei	Document Period End Date DocumentPeriodEndDate	2023-10-31
CY2023Q4	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q4	dei	Entity File Number EntityFileNumber	1-37782
CY2023Q4	dei	Entity Registrant Name EntityRegistrantName	ZEDGE, INC.
CY2023Q4	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023Q4	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	26-3199071
CY2023Q4	dei	Entity Address Address Line1 EntityAddressAddressLine1	1178 Broadway
CY2023Q4	dei	Entity Address Address Line2 EntityAddressAddressLine2	3rd Floor #1450
CY2023Q4	dei	Entity Address City Or Town EntityAddressCityOrTown	New York
CY2023Q4	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
CY2023Q4	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	10001
CY2023Q4	dei	City Area Code CityAreaCode	(330)
CY2023Q4	dei	Local Phone Number LocalPhoneNumber	577-3424
CY2023Q4	dei	Security12b Title Security12bTitle	Class B common stock, par value $.01 per share
CY2023Q4	dei	Security Exchange Name SecurityExchangeName	NYSE
CY2023Q4	dei	Trading Symbol TradingSymbol	ZDGE
CY2023Q4	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3183000	usd
CY2023Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2883000	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	635000	usd
CY2023Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	569000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	22563000	usd
CY2023Q3	us-gaap	Assets Current AssetsCurrent	21577000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2423000	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2186000	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	18130000	usd
CY2023Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	18709000	usd
CY2023Q4	us-gaap	Goodwill Goodwill	1784000	usd
CY2023Q3	us-gaap	Goodwill Goodwill	1961000	usd
CY2023Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	1842000	usd
CY2023Q3	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	1842000	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	439000	usd
CY2023Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	556000	usd
CY2023Q4	us-gaap	Assets Assets	47181000	usd
CY2023Q3	us-gaap	Assets Assets	46831000	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	815000	usd
CY2023Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	669000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2906000	usd
CY2023Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2676000	usd
CY2023Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	2250000	usd
CY2023Q3	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	2414000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	5971000	usd
CY2023Q3	us-gaap	Liabilities Current LiabilitiesCurrent	5759000	usd
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1986000	usd
CY2023Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1985000	usd
CY2023Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	74000	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	171000	usd
CY2023Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	223000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	8202000	usd
CY2023Q3	us-gaap	Liabilities Liabilities	7967000	usd
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2023Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2400000	shares
CY2023Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2400000	shares
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	46631000	usd
CY2023Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	46122000	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1904000	usd
CY2023Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1537000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-3957000	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-3942000	usd
CY2023Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	839000	shares
CY2023Q3	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	833000	shares
CY2023Q4	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	1943000	usd
CY2023Q3	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	1930000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	38979000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	38864000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	47181000	usd
CY2023Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	46831000	usd
CY2023Q4	us-gaap	Revenues Revenues	7081000	usd
CY2022Q4	us-gaap	Revenues Revenues	6900000	usd
CY2023Q4	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	486000	usd
CY2022Q4	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	632000	usd
CY2023Q4	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	5499000	usd
CY2022Q4	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	5826000	usd
CY2023Q4	us-gaap	Depreciation And Amortization DepreciationAndAmortization	775000	usd
CY2022Q4	us-gaap	Depreciation And Amortization DepreciationAndAmortization	793000	usd
CY2022Q4	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-150000	usd
CY2023Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	321000	usd
CY2022Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-201000	usd
CY2023Q4	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	81000	usd
CY2022Q4	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	35000	usd
CY2023Q4	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-219000	usd
CY2022Q4	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-76000	usd
CY2023Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	183000	usd
CY2022Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-242000	usd
CY2023Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	198000	usd
CY2022Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-73000	usd
CY2023Q4	us-gaap	Net Income Loss NetIncomeLoss	-15000	usd
CY2022Q4	us-gaap	Net Income Loss NetIncomeLoss	-169000	usd
CY2023Q4	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	367000	usd
CY2022Q4	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	259000	usd
CY2023Q4	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-367000	usd
CY2022Q4	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-259000	usd
CY2023Q4	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-382000	usd
CY2022Q4	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-428000	usd
CY2022Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
CY2022Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.01
CY2023Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	13975000	shares
CY2022Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	14330000	shares
CY2023Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	13975000	shares
CY2022Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	14330000	shares
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	38864000	usd
CY2023Q4	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	3000	usd
CY2023Q4	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	507000	usd
CY2023Q4	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	13000	usd
CY2023Q4	us-gaap	Temporary Equity Foreign Currency Translation Adjustments TemporaryEquityForeignCurrencyTranslationAdjustments	-367000	usd
CY2023Q4	us-gaap	Net Income Loss NetIncomeLoss	-15000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	38979000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	44188000	usd
CY2022Q4	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	590000	usd
CY2022Q4	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	310000	usd
CY2022Q4	us-gaap	Temporary Equity Foreign Currency Translation Adjustments TemporaryEquityForeignCurrencyTranslationAdjustments	-259000	usd
CY2022Q4	us-gaap	Net Income Loss NetIncomeLoss	-169000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	44040000	usd
CY2023Q4	us-gaap	Net Income Loss NetIncomeLoss	-15000	usd
CY2022Q4	us-gaap	Net Income Loss NetIncomeLoss	-169000	usd
CY2023Q4	us-gaap	Depreciation Depreciation	14000	usd
CY2022Q4	us-gaap	Depreciation Depreciation	14000	usd
CY2023Q4	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	579000	usd
CY2022Q4	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	579000	usd
CY2023Q4	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	182000	usd
CY2022Q4	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	200000	usd
CY2023Q4	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1000	usd
CY2023Q4	zdge	Impairment Of Investment In Privately Held Company ImpairmentOfInvestmentInPrivatelyHeldCompany	50000	usd
CY2022Q4	zdge	Change In Fair Value Of Contingent Consideration ChangeInFairValueOfContingentConsideration	-150000	usd
CY2023Q4	us-gaap	Share Based Compensation ShareBasedCompensation	507000	usd
CY2022Q4	us-gaap	Share Based Compensation ShareBasedCompensation	589000	usd
CY2023Q4	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	300000	usd
CY2022Q4	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	70000	usd
CY2023Q4	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	66000	usd
CY2022Q4	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	205000	usd
CY2023Q4	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-14000	usd
CY2022Q4	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-14000	usd
CY2023Q4	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	384000	usd
CY2022Q4	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	598000	usd
CY2023Q4	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-90000	usd
CY2022Q4	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-318000	usd
CY2023Q4	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1260000	usd
CY2022Q4	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1082000	usd
CY2022Q4	us-gaap	Payments To Acquire Other Productive Assets PaymentsToAcquireOtherProductiveAssets	962000	usd
CY2023Q4	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	423000	usd
CY2022Q4	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	310000	usd
CY2023Q4	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	22000	usd
CY2022Q4	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	39000	usd
CY2023Q4	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-445000	usd
CY2022Q4	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1311000	usd
CY2022Q4	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	2000000	usd
CY2022Q4	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	18000	usd
CY2023Q4	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	3000	usd
CY2023Q4	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	13000	usd
CY2022Q4	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	310000	usd
CY2023Q4	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-10000	usd
CY2022Q4	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1672000	usd
CY2023Q4	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-185000	usd
CY2022Q4	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-109000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	620000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	1334000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	18125000	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	17085000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	18745000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	18419000	usd
CY2023Q4	us-gaap	Income Taxes Paid IncomeTaxesPaid	36000	usd
CY2023Q4	us-gaap	Interest Paid Net InterestPaidNet	46000	usd
CY2023Q4	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2	pure
CY2023Q4	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Use of Estimates</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The preparation of the Company’s unaudited condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue and expenses, as well as related disclosure of contingent assets and liabilities. Actual results could differ materially from the Company’s estimates due to risks and uncertainties, including uncertainty in the economic environment due to various global events. To the extent that there are material differences between these estimates and actual results, the Company’s financial condition or operating results will be affected. The Company bases its estimates on past experience and other assumptions that the Company believes are reasonable under the circumstances, and the Company evaluates these estimates on an ongoing basis.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> </p>
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	18130000	usd
CY2023Q4	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	579000	usd
CY2022Q4	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	579000	usd
CY2023Q4	us-gaap	Revenues Revenues	7081000	usd
CY2022Q4	us-gaap	Revenues Revenues	6900000	usd
CY2023Q4	zdge	Deferred Revenue Descriptions DeferredRevenueDescriptions	The Company records deferred revenues related to the unsatisfied performance obligations with respect to subscription revenue. The Company’s deferred revenue balance related to paid subscriptions was approximately $1.7 million related to approximately 648,000 active subscribers, and approximately $1.5 million, related to approximately 647,000 active subscribers as of October 31, 2023 and July 31, 2023, respectively.
CY2023Q4	us-gaap	Foreign Currency Fair Value Hedge Liability At Fair Value ForeignCurrencyFairValueHedgeLiabilityAtFairValue	208000	usd
CY2023Q3	us-gaap	Foreign Currency Fair Value Hedge Asset At Fair Value ForeignCurrencyFairValueHedgeAssetAtFairValue	19000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2906000	usd
CY2023Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2676000	usd
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P4Y
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P3Y
CY2023Q4	us-gaap	Derivative Notional Amount DerivativeNotionalAmount	1575000000	usd
CY2023Q4	us-gaap	Derivative Notional Amount DerivativeNotionalAmount	15727140000	nok
CY2023Q4	us-gaap	Derivative Notional Amount DerivativeNotionalAmount	1575000000	usd
CY2023Q4	us-gaap	Derivative Notional Amount DerivativeNotionalAmount	1441792000	eur
CY2023Q4	us-gaap	Gain Loss On Foreign Currency Derivative Instruments Not Designated As Hedging Instruments GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments	282000	usd
CY2022Q4	us-gaap	Gain Loss On Foreign Currency Derivative Instruments Not Designated As Hedging Instruments GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments	-121000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	1736000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	2315000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	2315000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	2315000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	2315000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	7134000	usd
CY2023Q4	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1		usd
CY2023Q3	us-gaap	Goodwill Goodwill	1961000	usd
CY2023Q4	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	-177000	usd
CY2023Q4	us-gaap	Goodwill Goodwill	1784000	usd
CY2023Q4	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss	8700000	usd
CY2023Q4	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	764000	usd
CY2023Q3	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	1136000	usd
CY2023Q4	us-gaap	Accrued Vacation Current AccruedVacationCurrent	590000	usd
CY2023Q3	us-gaap	Accrued Vacation Current AccruedVacationCurrent	593000	usd
CY2023Q4	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	285000	usd
CY2023Q3	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	237000	usd
CY2023Q4	zdge	Due To Affiliates Current DueToAffiliatesCurrent	310000	usd
CY2023Q3	zdge	Due To Affiliates Current DueToAffiliatesCurrent	226000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current And Noncurrent AccruedLiabilitiesCurrentAndNoncurrent	573000	usd
CY2023Q3	us-gaap	Accrued Liabilities Current And Noncurrent AccruedLiabilitiesCurrentAndNoncurrent	301000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	122000	usd
CY2023Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	124000	usd
CY2023Q4	zdge	Derivative Liability For Foreign Exchange Contracts DerivativeLiabilityForForeignExchangeContracts	208000	usd
CY2023Q4	us-gaap	Accrued Income Taxes AccruedIncomeTaxes	41000	usd
CY2023Q3	us-gaap	Accrued Income Taxes AccruedIncomeTaxes	51000	usd
CY2023Q4	zdge	Due To Related Party Idt DueToRelatedPartyIDT	13000	usd
CY2023Q3	zdge	Due To Related Party Idt DueToRelatedPartyIDT	8000	usd
CY2023Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic
CY2023Q4	us-gaap	Share Based Compensation ShareBasedCompensation	507000	usd
CY2022Q4	us-gaap	Share Based Compensation ShareBasedCompensation	589000	usd
CY2023Q4	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	277000	usd
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	456000	shares
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Nonvested SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested	4000000	usd
CY2023Q4	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	13000	usd
CY2022Q4	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	17000	usd
CY2022Q4	us-gaap	Stock Option Exercise Price Increase StockOptionExercisePriceIncrease	2.27
CY2023Q4	zdge	Vesting Percentage Description VestingPercentageDescription	Except for the modification to the exercise price of the Eligible Stock Options, all other terms and conditions of each of the Eligible Stock Options remained in full force and effect.
CY2022Q4	us-gaap	Stockholders Equity Other Shares StockholdersEquityOtherShares	191663	shares
CY2023Q1	zdge	Incremental Stock Based Compensation IncrementalStockBasedCompensation	87000	usd
CY2023Q1	us-gaap	Other Expenses OtherExpenses	39000	usd
CY2023Q1	zdge	Recognized Expenses RecognizedExpenses	48000	usd
CY2023Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	13975000	shares
CY2022Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	14330000	shares
CY2023Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	13975000	shares
CY2022Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	14330000	shares
CY2023Q4	us-gaap	Stock Dividends Shares StockDividendsShares	855000	shares
CY2022Q4	us-gaap	Stock Dividends Shares StockDividendsShares	858000	shares
CY2023Q4	us-gaap	Incremental Common Shares Attributable To Nonvested Shares With Forfeitable Dividends IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends	308000	shares
CY2022Q4	us-gaap	Incremental Common Shares Attributable To Nonvested Shares With Forfeitable Dividends IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends	679000	shares
CY2023Q4	us-gaap	Stock Issued During Period Shares Conversion Of Units StockIssuedDuringPeriodSharesConversionOfUnits	203000	shares
CY2022Q4	us-gaap	Stock Issued During Period Shares Conversion Of Units StockIssuedDuringPeriodSharesConversionOfUnits	239000	shares
CY2023Q4	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1366000	shares
CY2022Q4	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1776000	shares
CY2023Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted
CY2022Q4	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts		usd
CY2023Q4	us-gaap	Other Commitment Due In Second And Third Year OtherCommitmentDueInSecondAndThirdYear	4000000	usd
CY2023Q4	zdge	Payable Over Period PayableOverPeriod	P3Y
CY2016Q3	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	2500000	usd
CY2023Q4	us-gaap	Line Of Credit Facility Interest Rate Description LineOfCreditFacilityInterestRateDescription	Previously the interest rate was capped at 5.0%. Interest was payable monthly and all outstanding principal and any accrued and unpaid interest was due on the maturity date of September 26, 2022.
CY2023Q4	us-gaap	Line Of Credit Facility Interest Rate At Period End LineOfCreditFacilityInterestRateAtPeriodEnd	0.05	pure
CY2023Q4	us-gaap	Line Of Credit Facility Collateral Fees Amount LineOfCreditFacilityCollateralFeesAmount	10000	usd
CY2023Q4	us-gaap	Line Of Credit Facility Description LineOfCreditFacilityDescription	On October 28, 2022, the Company entered into an Amended and Restated Loan and Security Agreement (“Amended Loan Agreement”) with WAB. Pursuant to the Amended Loan Agreement, WAB agreed to provide the Company with a new term loan facility in the maximum principal amount of $7 million for a four-year term and a $4 million revolving credit facility for a two-year term.
CY2023Q4	us-gaap	Line Of Credit Facility Periodic Payment Principal LineOfCreditFacilityPeriodicPaymentPrincipal	2000000	usd
CY2022Q4	us-gaap	Line Of Credit Facility Periodic Payment Principal LineOfCreditFacilityPeriodicPaymentPrincipal	2000000	usd
CY2022Q4	us-gaap	Line Of Credit Facility Periodic Payment LineOfCreditFacilityPeriodicPayment	5000000	usd
CY2023Q4	us-gaap	Line Of Credit Facility Annual Principal Payment LineOfCreditFacilityAnnualPrincipalPayment	1000000	usd
CY2023Q4	us-gaap	Long Term Debt Percentage Bearing Fixed Interest Rate LongTermDebtPercentageBearingFixedInterestRate	0.10	pure
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	50000	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	200000	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	200000	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	1550000	usd
CY2023Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	2000000	usd
CY2023Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	14000	usd
CY2023Q4	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	1986000	usd
CY2023Q4	us-gaap	Line Of Credit Facility Periodic Payment Principal LineOfCreditFacilityPeriodicPaymentPrincipal	2000000	usd
CY2023Q4	us-gaap	Line Of Credit Facility Borrowing Capacity Description LineOfCreditFacilityBorrowingCapacityDescription	As of November 16, 2016, the Company entered into a Foreign Exchange Agreement with WAB to allow the Company to enter into foreign exchange contracts not to exceed $5.0 million in the aggregate at any point in time under its revolving credit facility. This limit was raised to approximately $7.5 million pursuant to the Loan and Security Modification Agreement dated May 30, 2018. The available borrowing under the revolving credit facility is reduced by an applicable foreign exchange reserve percentage as determined by WAB, in its reasonable discretion from time to time, which was set at 10% of the nominal amount of the foreign exchange contracts in effect at the relevant time.
CY2023Q4	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	pure
CY2023Q4	us-gaap	Revenues Revenues	7081000	usd
CY2022Q4	us-gaap	Revenues Revenues	6900000	usd
CY2023Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	321000	usd
CY2022Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-201000	usd
CY2023Q4	us-gaap	Assets Held For Sale Long Lived Fair Value Disclosure AssetsHeldForSaleLongLivedFairValueDisclosure	20991000	usd
CY2023Q3	us-gaap	Assets Held For Sale Long Lived Fair Value Disclosure AssetsHeldForSaleLongLivedFairValueDisclosure	21400000	usd
CY2023Q4	us-gaap	Assets Designated To Closed Block Other Long Term Investments AssetsDesignatedToClosedBlockOtherLongTermInvestments	47181000	usd
CY2023Q3	us-gaap	Assets Designated To Closed Block Other Long Term Investments AssetsDesignatedToClosedBlockOtherLongTermInvestments	46831000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	302000000	usd
CY2023Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	360000000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	3700000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	1800000	usd
CY2022Q4	zdge	Impairment Of Investment In Privately Held Company ImpairmentOfInvestmentInPrivatelyHeldCompany		usd
CY2023Q4	zdge	Change In Fair Value Of Contingent Consideration ChangeInFairValueOfContingentConsideration		usd
CY2023Q4	us-gaap	Payments To Acquire Other Productive Assets PaymentsToAcquireOtherProductiveAssets		usd
CY2023Q4	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt		usd
CY2023Q4	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts		usd
CY2022Q4	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised		usd
CY2022Q4	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
CY2022Q4	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2023Q4	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants		shares
CY2022Q4	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants		shares
CY2023Q4	zdge	Nonvested Restricted Class B Common Stock NonvestedRestrictedClassBCommonStock		shares
CY2022Q4	zdge	Nonvested Restricted Class B Common Stock NonvestedRestrictedClassBCommonStock		shares
CY2023Q4	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements		shares
CY2022Q4	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements		shares
CY2023Q4	dei	Amendment Flag AmendmentFlag	false
CY2023Q4	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--07-31
CY2023Q4	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q4	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2023Q4	dei	Entity Central Index Key EntityCentralIndexKey	0001667313
CY2023Q4	zdge	Balance Of Maximum Debt BalanceOfMaximumDebt	To be agreed upon

Files In Submission

Name	View Source	Status
0001213900-23-095720-index-headers.html	Edgar Link	pending
0001213900-23-095720-index.html	Edgar Link	pending
0001213900-23-095720.txt	Edgar Link	pending
0001213900-23-095720-xbrl.zip	Edgar Link	pending
f10q1023ex31-1_zedgeinc.htm	Edgar Link	pending
f10q1023ex31-2_zedgeinc.htm	Edgar Link	pending
f10q1023ex32-1_zedgeinc.htm	Edgar Link	pending
f10q1023ex32-2_zedgeinc.htm	Edgar Link	pending
f10q1023_zedgeinc.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image_001.jpg	Edgar Link	pending
image_002.jpg	Edgar Link	pending
image_003.jpg	Edgar Link	pending
image_004.jpg	Edgar Link	pending
f10q1023_zedgeinc_htm.xml	Edgar Link	completed
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
zdge-20231031.xsd	Edgar Link	pending
zdge-20231031_cal.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
zdge-20231031_def.xml	Edgar Link	unprocessable
zdge-20231031_lab.xml	Edgar Link	unprocessable
zdge-20231031_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ZDGE
Zedge, Inc. Stock $zdge

2023 Q4 Form 10-Q Financial Statement

#000121390023095720 Filed on December 14, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ZDGE Zedge, Inc. Stock $zdge

2023 Q4 Form 10-Q Financial Statement

#000121390023095720 Filed on December 14, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ZDGE
Zedge, Inc. Stock $zdge